EU extends IMS Health, Cegedim review following remedies
IMS Health Holdings, a company that sells prescription data and consulting services to drugmakers, is seeking to overcome EU antitrust concerns by offering to revise the terms of its proposed buyout...To view the full article, register now.
Already a subscriber? Click here to view full article